Contents
Chapter 1: Overview of the Immune System
A Historical Perspective of Immunology
Early Vaccination Studies Led the Way to Immunology
Vaccination Is an Ongoing, Worldwide Enterprise
Immunology Is about More than Just Vaccines and Infectious Disease
Immunity Involves Both Humoral and Cellular Components
How Are Foreign Substances Recognized by the Immune System?
Important Concepts for Understanding the Mammalian Immune Response
Pathogens Come in Many Forms and Must First Breach Natural Barriers
The Immune Response Quickly Becomes Tailored to Suit the Assault
Pathogen Recognition Molecules Can Be Encoded as Genes or Generated by DNA Rearrangement
Tolerance Ensures That the Immune System Avoids Destroying the Host
The Immune Response Is Composed of Two Interconnected Arms: Innate Immunity and Adaptive Immunity
Immune Cells and Molecules Can Be Found in Many Places
Adaptive Immune Responses Typically Generate Memory
The Good, Bad, and Ugly of the Immune System
Inappropriate or Dysfunctional Immune Responses Can Result in a Range of Disorders
The Immune Response Renders Tissue Transplantation Challenging
Cancer Presents a Unique Challenge to the Immune Response
Conclusion
References
Study Questions
Chapter 2: Cells, Organs, and Microenvironments of the Immune System
Hematopoiesis and Cells of the Immune System
Hematopoietic Stem Cells Differentiate into All Red and White Blood Cells
HSCs Differentiate into Myeloid and Lymphoid Blood Cell Lineages
Cells of the Myeloid Lineage Are the First Responders to Infection
Cells of the Lymphoid Lineage Regulate the Adaptive Immune Response
Primary Lymphoid Organs: Where Immune Cells Develop
The Site of Hematopoiesis Changes during Embryonic Development
The Bone Marrow Is the Main Site of Hematopoiesis in the Adult
The Thymus Is the Primary Lymphoid Organ Where T Cells Mature
Secondary Lymphoid Organs: Where the Immune Response Is Initiated
Secondary Lymphoid Organs Are Distributed throughout the Body and Share Some Anatomical Features
Blood and Lymphatics Connect Lymphoid Organs and Infected Tissue
The Lymph Node Is a Highly Specialized Secondary Lymphoid Organ
The Spleen Organizes the Immune Response against Blood-Borne Pathogens
Barrier Organs Also Have Secondary Lymphoid Tissue
Tertiary Lymphoid Tissues Also Organize and Maintain an Immune Response
Conclusion
References
Study Questions
Chapter 3: Recognition and Response
General Properties of Immune Receptor-Ligand Interactions
Receptor-Ligand Binding Occurs via Multiple Noncovalent Bonds
How Do We Describe the Strength of Receptor-Ligand Interactions?
Interactions between Receptors and Ligands Can Be Multivalent
Combinatorial Expression of Protein Chains Can Increase Ligand-Binding Diversity
Adaptive Immune Receptor Genes Undergo Rearrangement in Individual Lymphocytes
Levels of Receptor and Ligand Expression Can Vary during an Immune Response
Local Concentrations of Ligands May Be Extremely High during Cell-Cell Interactions
Many Immune Receptors Include Immunoglobulin Domains
Immune Antigen Receptors Can Be Transmembrane, Cytosolic, or Secreted
Immune Antigen Receptor Systems
The B-Cell Receptor Has the Same Antigen Specificity as Its Secreted Antibodies
T-Cell Antigen Receptors Recognize Antigen in the Context of MHC Proteins
Receptors of Innate Immunity Bind to Conserved Molecules on Pathogens
Cytokines and Their Receptors
Cytokines Are Described by Their Functions and the Distances at Which They Act
Cytokines Exhibit the Attributes of Pleiotropy, Redundancy, Synergism, Antagonism, and Cascade Induction
Cytokines of the IL-1 Family Promote Proinflammatory Signals
Class 1 Cytokines Share a Common Structural Motif But Have Varied Functions
Class 2 Cytokines Are Grouped into Three Families of Interferons
TNF Family Cytokines May Be Soluble or Membrane-Bound
The IL-17 Family of Cytokines and Receptors Is the Most Recently Identified
Chemokines Induce the Directed Movement of Leukocytes
A Conceptual Framework for Understanding Cell Signaling
Ligand Binding Can Induce Dimerization or Multimerization of Receptors
Ligand Binding Can Induce Phosphorylation of Tyrosine Residues in Receptors or Receptor-Associated Molecules
Src-Family Kinases Play Important Early Roles in the Activation of Many Immune Cells
Intracellular Adapter Proteins Gather Members of Signaling Pathways
Common Sequences of Downstream Effector Relays Pass the Signal to the Nucleus
Not All Ligand-Receptor Signals Result in Transcriptional Alterations
Immune Responses: The Outcomes of Immune System Recognition
Changes in Protein Expression Facilitate Migration of Leukocytes into Infected Tissues
Activated Macrophages and Neutrophils May Clear Pathogens without Invoking Adaptive Immunity
Antigen Activation Optimizes Antigen Presentation by Dendritic Cells
Cytokine Secretion by Dendritic Cells and T Cells Can Direct the Subsequent Immune Response
Antigen Stimulation by T and B Cells Promotes Their Longer-Term Survival
Antigen Binding by T Cells Induces Their Division and Differentiation
Antigen Binding by B Cells Induces Their Division and Differentiation
Conclusion
References
Study Questions
Chapter 4: Innate Immunity
Anatomical Barriers to Infection
Epithelial Barriers Prevent Pathogen Entry into the Body’s Interior
Antimicrobial Proteins and Peptides Kill Would-Be Invaders
Cellular Innate Response Receptors and Signaling
Toll-Like Receptors Initiate Responses to Many Types of Molecules from Extracellular Pathogens
C-Type Lectin Receptors Bind Carbohydrates on the Surfaces of Extracellular Pathogens
NOD-Like Receptors Bind PAMPs from Cytosolic Pathogens
ALRs Bind Cytosolic DNA
RLRs Bind Cytosolic Viral RNA
cGAS and STING Are Activated by Cytosolic DNA and Dinucleotides
Induced Innate Immunity Effector Mechanisms
Expression of Innate Immunity Proteins Is Induced by PRR Signaling
Phagocytosis Is an Important Mechanism for Eliminating Pathogens
Regulated Cell Death Contributes to Pathogen Elimination
Local Inflammation Is Triggered by Innate Immune Responses
Innate Lymphoid Cells
Natural Killer Cells Are ILCs with Cytotoxic Activity
ILC Populations Produce Distinct Cytokines and Have Different Roles
Regulation and Evasion of Innate and Inflammatory Responses
Innate and Inflammatory Responses Can Be Harmful
Innate and Inflammatory Responses Are Regulated Both Positively and Negatively
Pathogens Have Evolved Mechanisms to Evade Innate and Inflammatory Responses
Interactions between the Innate and Adaptive Immune Systems
The Innate Immune System Activates Adaptive Immune Responses
Recognition of Pathogens by Dendritic Cells Influences Helper T-Cell Differentiation
Some Antigens Containing PAMPs Can Activate B Cells Independent of Helper T Cells
Adjuvants Activate Innate Immune Responses That Increase the Effectiveness of Immunizations
Some Pathogen Clearance Mechanisms Are Common to Both Innate and Adaptive Immune Responses
Ubiquity of Innate Immunity
Some Innate Immune System Components Occur across the Plant and Animal Kingdoms
Invertebrate and Vertebrate Innate Immune Responses Show Both Similarities and Differences
Conclusion
References
Study Questions
Chapter 5: The Complement System
The Major Pathways of Complement Activation
The Classical Pathway Is Initiated by Antibody Binding to Antigens
The Lectin Pathway Is Initiated When Soluble Proteins Recognize Microbial Antigens
The Alternative Pathway Is Initiated in Three Distinct Ways
The Three Complement Pathways Converge at the Formation of C5 Convertase and Generation of the MAC
The Diverse Functions of Complement
Complement Receptors Connect Complement-Tagged Pathogens to Effector Cells
Complement Enhances Host Defense against Infection
Complement Acts at the Interface between Innate and Adaptive Immunities
Complement Aids in the Contraction Phase of the Immune Response
The Regulation of Complement Activity
Complement Activity Is Passively Regulated by Short Protein Half-Lives and Host Cell Surface Composition
The C1 Inhibitor, C1INH, Promotes Dissociation of C1 Components
Decay-Accelerating Factor Promotes Decay of C3 Convertases
Factor I Degrades C3b and C4b
CD59 (Protectin) Inhibits the MAC Attack
Carboxypeptidases Can Inactivate the Anaphylatoxins C3a and C5a
Complement Deficiencies
Microbial Complement Evasion Strategies
The Evolutionary Origins of the Complement System
Conclusion
References
Study Questions
Chapter 6: The Organization and Expression of Lymphocyte Receptor Genes
The Puzzle of Immunoglobulin Gene Structure
Investigators Proposed Two Early Theoretical Models of Antibody Genetics
Breakthrough Experiments Revealed That Multiple Gene Segments Encode the Immunoglobulin Light Chain
Multigene Organization of Immunoglobulin Genes
κ Light-Chain Genes Include V, J, and C Segments
λ Light-Chain Genes Include Paired J and C Segments
Heavy-Chain Gene Organization Includes V
H
, D, J
H
, and C
H
Segments
The Antibody Genes Found in Mature B Cells Are the Product of DNA Recombination
The Mechanism of V(D)J Recombination
V(D)J Recombination in Lymphocytes Is a Highly Regulated Sequential Process
Recombination Is Directed by Recombination Signal Sequences
Gene Segments Are Joined by a Diverse Group of Proteins
V(D)J Recombination Occurs in a Series of Well-Regulated Steps
Five Mechanisms Generate Antibody Diversity in Naïve B Cells
The Regulation of V(D)J Gene Recombination Involves Chromatin Alteration
B-Cell Receptor Expression
Each B Cell Synthesizes only one Heavy Chain and One Light Chain
Receptor Editing of Potentially Autoreactive Receptors Occurs in Light Chains
mRNA Splicing Regulates the Expression of Membrane-Bound versus Secreted Ig
T-Cell Receptor Genes and Their Expression
Understanding the Protein Structure of the TCR Was Critical to the Process of Discovering the Genes
The β-Chain Gene Was Discovered Simultaneously in Two Different Laboratories
A Search for the α-Chain Gene Led to the γ-Chain Gene Instead
TCR Genes Are Arranged in V, D, and J Clusters of Gene Segments
Recombination of TCR Gene Segments Proceeds at a Different Rate and Occurs at Different Stages of Development in αβ versus γδ T Cells
The Process of TCR Gene Segment Rearrangement Is Very Similar to Immunoglobulin Gene Recombination
TCR Expression Is Controlled by Allelic Exclusion
Conclusion
References
Study Questions
Chapter 7: The Major Histocompatibility Complex and Antigen Presentation
The Structure and Function of MHC Class I and II Molecules
Class I Molecules Consist of One Large Glycoprotein Heavy Chain Plus a Small Protein Light Chain
Class II Molecules Consist of Two Nonidentical Membrane-Bound Glycoprotein Chains
Class I and II Molecules Exhibit Polymorphism in the Region That Binds to Peptides
The Organization and Inheritance of MHC Genes
The MHC Locus Encodes the Three Major Classes of MHC Molecules
Allelic Forms of MHC Genes Are Inherited in Linked Groups Called Haplotypes
MHC Molecules Are Codominantly Expressed
Class I and Class II Molecules Exhibit Diversity at Both the Individual and Species Levels
MHC Polymorphism Is Primarily Limited to the Antigen-Binding Groove
The Role and Expression Pattern of MHC Molecules
MHC Molecules Present Both Intracellular and Extracellular Antigens
MHC Class I Expression Is Found Throughout the Body
Expression of MHC Class II Molecules Is Primarily Restricted to Antigen-Presenting Cells
MHC Expression Can Change with Changing Conditions
MHC Alleles Play a Critical Role in Immune Responsiveness
Seminal Studies Demonstrate That T Cells Recognize Peptide Presented in the Context of Self-MHC Alleles
Evidence Suggests Distinct Antigen Processing and Presentation Pathways
The Endogenous Pathway of Antigen Processing and Presentation
Peptides Are Generated by Protease Complexes Called Proteasomes
Peptides Are Transported from the Cytosol to the Rough Endoplasmic Reticulum
Chaperones Aid Peptide Assembly with MHC Class I Molecules
The Exogenous Pathway of Antigen Processing and Presentation
Peptides Are Generated from Internalized Antigens in Endocytic Vesicles
The Invariant Chain Guides Transport of MHC Class II Molecules to Endocytic Vesicles
Peptides Assemble with MHC Class II Molecules by Displacing CLIP
Unconventional Antigen Processing and Presentation
Dendritic Cells Can Cross-Present Exogenous Antigen via MHC Class I Molecules
Cross-Presentation by APCs Is Essential for the Activation of Naïve CD8
+
T Cells
Presentation of Nonpeptide Antigens
Conclusion
References
Study Questions
Chapter 8: T-Cell Development
Early Thymocyte Development
Thymocytes Progress through Four Double-Negative Stages
Thymocytes Express Either αβ or γδ T Cell Receptors
DN Thymocytes Undergo β-Selection, Which Results in Proliferation and Differentiation
Positive and Negative Selection
Thymocytes “Learn” MHC Restriction in the Thymus
T Cells Undergo Positive and Negative Selection
Positive Selection Ensures MHC Restriction
Negative Selection (Central Tolerance) Ensures Self-Tolerance
The Selection Paradox: Why Don’t We Delete All Cells We Positively Select?
An Alternative Model Can Explain the Thymic Selection Paradox
Do Positive and Negative Selection Occur at the Same Stage of Development, or in Sequence?
Lineage Commitment
Several Models Have Been Proposed to Explain Lineage Commitment
Transcription Factors Th-POK and Runx3 Regulate Lineage Commitment
Double-Positive Thymocytes May Commit to Other Types of Lymphocytes
Exit from the Thymus and Final Maturation
Other Mechanisms That Maintain Self-Tolerance
T
REG
Cells Negatively Regulate Immune Responses
Peripheral Mechanisms of Tolerance Also Protect against Autoreactive Thymocytes
Conclusion
References
Study Questions
Chapter 9: B-Cell Development
B-Cell Development in the Bone Marrow
Changes in Cell-Surface Markers, Gene Expression, and Immunoglobulin Gene Rearrangements Define the Stages of B-Cell Development
The Earliest Steps in Lymphocyte Differentiation Culminate in the Generation of a Common Lymphoid Progenitor
The Later Stages of B-Cell Development Result in Commitment to the B-Cell Phenotype and the Stepwise Rearrangement of Immunoglobulin Genes
Immature B Cells in the Bone Marrow Are Exquisitely Sensitive to Tolerance Induction through the Elimination of Self-Reactive Cells
Completion of B-Cell Development in the Spleen
T1 and T2 Transitional B Cells Form in the Spleen and Undergo Selection for Survival and against Self-Reactivity
T2 B Cells Give Rise to Mature Follicular B-2 B Cells
T3 B Cells Are Primarily Self-Reactive and Anergic
The Properties and Development of B-1 and Marginal Zone B Cells
B-1a, B-1b, and MZ B Cells Differ Phenotypically and Functionally from B-2 B Cells
B-1a B Cells Are Derived from a Distinct Developmental Lineage
Comparison of B- and T-Cell Development
Conclusion
References
Study Questions
Chapter 10: T-Cell Activation, Helper Subset Differentiation, and Memory
T-Cell Activation and the Two-Signal Hypothesis
TCR Signaling Provides Signal 1 and Sets the Stage for T-Cell Activation
Costimulatory Signals Are Required for Optimal T-Cell Activation Whereas Coinhibitory Signals Prevent T-Cell Activation
Clonal Anergy Results If a Costimulatory Signal Is Absent
Cytokines Provide Signal 3
Antigen-Presenting Cells Provide Costimulatory Ligands and Cytokines to Naïve T Cells
Superantigens Are a Special Class of T-Cell Activators
Helper CD4
+
T-Cell Differentiation
Helper T Cells Can Be Divided into Distinct Subsets and Coordinate Type 1 and Type 2 Responses
The Differentiation of Helper T-Cell Subsets Is Regulated by Polarizing Cytokines
Each Effector Helper T-Cell Subset Has Unique Properties
Helper T Cells May Not Be Irrevocably Committed to a Lineage
Helper T-Cell Subsets Play Critical Roles in Immune Health and Disease
T-Cell Memory
Naïve, Effector, and Memory T Cells Can Be Distinguished by Differences in Surface Protein Expression
Memory Cell Subpopulations Are Distinguished by Their Locale and Effector Activity
Many Questions Remain Surrounding Memory T-Cell Origins and Functions
Conclusion
References
Study Questions
Chapter 11: B-Cell Activation, Differentiation, and Memory Generation
T-Dependent B-Cell Responses: Activation
Naïve B Cells Encounter Antigen in the Lymph Nodes and Spleen
B-Cell Recognition of Cell-Bound Antigen Culminates in the Formation of an Immunological Synapse
Antigen Binding to the BCR Leads to Activation of a Signal Transduction Cascade within the B Cell
B Cells Also Receive and Propagate Signals through Coreceptors
B Cells Use More Than One Mechanism to Acquire Antigen from Antigen-Presenting Cells
Antigen Receptor Binding Induces Internalization and Antigen Presentation
The Early Phases of the T-Dependent Response Are Characterized by Chemokine-Directed B-Cell Migration
Specification of the Stimulated B-Cell Fate Depends on Transcription Factor Expression
T-Dependent B-Cell Responses: Differentiation and Memory Generation
Some Activated B Cells Differentiate into Plasma Cells That Form the Primary Focus
Other Activated B Cells Enter the Follicles and Initiate a Germinal Center Response
The Mechanisms of Somatic Hypermutation and Class Switch Recombination
Memory B Cells Recognizing T-Dependent Antigens Are Generated Both within and outside the Germinal Center
Most Newly Generated B Cells Are Lost at the End of the Primary Immune Response
T-Independent B-Cell Responses
T-Independent Antigens Stimulate Antibody Production in the Absence of T-Cell Help
Two Novel Subclasses of B Cells Mediate the Response to T-Independent Antigens
Negative Regulation of B Cells
Negative Signaling through CD22 Balances Positive BCR-Mediated Signaling
Negative Signaling through the Receptor FcγRIIb Inhibits B-Cell Activation
CD5 Acts as a Negative Regulator of B-Cell Signaling
B-10 B Cells Act as Negative Regulators by Secreting IL-10
Conclusion
References
Study Questions
Chapter 12: Effector Responses: Antibody- and Cell-Mediated Immunity
Antibody-Mediated Effector Functions
Antibodies Provide Protection against Pathogens, Toxins, and Harmful Cells in a Variety of Ways
Different Antibody Classes Mediate Different Effector Functions
Fc Receptors Mediate Many Effector Functions of Antibodies
Protective Effector Functions Vary among Antibody Classes
Antibodies Have Many Therapeutic Uses in Treating Diseases
Cell-Mediated Effector Responses
Cytotoxic T Lymphocytes Recognize and Kill Infected or Tumor Cells via T-Cell Receptor Activation
Natural Killer Cell Activity Depends on the Balance of Activating and Inhibitory Signals
NKT Cells Bridge the Innate and Adaptive Immune Systems
Conclusion
References
Study Questions
Chapter 13: Barrier Immunity: The Immunology of Mucosa and Skin
Common Themes in Barrier Immune Systems
All Barrier Surfaces Are Lined by One or More Layers of Epithelial Cells
Barrier Organs Are Populated by Innate and Adaptive Immune Cells That Interact with Epithelium and Secondary Lymphoid Tissue
Barrier Immune Systems Initiate Both Tolerogenic and Inflammatory Responses to Microorganisms
Intestinal Immunity
The Gut Is Organized into Different Anatomical Sections and Tissue Layers
Gut Epithelial Cells Vary in Phenotype and Function
Setting the Stage: Maintaining Immune Homeostasis in the Intestine
The Gut Immune System Maintains a Barrier between the Microbiome and the Epithelium
Antigen Is Delivered from the Intestinal Lumen to Antigen-Presenting Cells in Multiple Ways
Immune Homeostasis in the Intestine Is Promoted by Several Innate and Adaptive Cell Types
The Immune Systems in the Small and Large Intestines Differ
Commensal Microbes Help Maintain Tolerogenic Tone in the Intestine
Springing into Action: Intestinal Immune System Response to Invasion
The Gut Immune System Recognizes and Responds to Harmful Pathogens
The Intestinal Immune System Can Mount Both Type 1 and Type 2 Responses
Dysbiosis, Inflammatory Bowel Disease, and Celiac Disease
Other Barrier Immune Systems
The Respiratory Immune System Shares Many Features with the Intestinal Immune System
The Skin Is a Unique Barrier Immune System
Conclusion
References
Study Questions
Chapter 14: The Adaptive Immune Response in Space and Time
Immune Cells in Healthy Tissue: Homeostasis
Naïve Lymphocytes Circulate between Secondary and Tertiary Lymphoid Tissues
Extravasation Is Driven by Sequential Activation of Surface Molecules
Naïve Lymphocytes Browse for Antigen along the Reticular Network of Secondary Lymphoid Organs
Immune Cell Response to Antigen: The Innate Immune Response
Innate Immune Cells Are Activated by Antigen Binding to Pattern Recognition Receptors
Antigen Travels in Two Different Forms to Secondary Lymphoid Tissue via Afferent Lymphatics
Antigen-Presenting Cells Presenting Processed Antigen Travel to the T-Cell Zones of Secondary Lymphoid Tissue
Unprocessed Antigen Travels to the B-Cell Zones
Blood-Borne Antigen Is Captured by Specialized APCs at the Marginal Zone of the Spleen
First Contact between Antigen and Lymphocytes
Naïve CD4
+
T Cells Arrest Their Movements after Engaging Antigens
B Cells Seek Help from CD4
+
T Cells at the Border between the Follicle and Paracortex of the Lymph Node
Dynamic Imaging Adds New Perspectives on B- and T-Cell Behavior in Germinal Centers
CD8
+
T Cells Are Activated in the Lymph Node via a Multicellular Interaction
A Summary of the Timing of a Primary Response
Differentiation into Central Memory T Cells Begins Early in the Primary Response
The Immune Response Contracts within 10 to 14 Days
The Effector and Memory Cell Response
Activated Lymphocytes Exit the Lymph Node and Recirculate through Various Tissues
Chemokine Receptors and Adhesion Molecules Regulate Homing of Memory and Effector Lymphocytes to Peripheral Tissues
The Immune Response: Case Studies
CD8
+
T-Cell Response to Infection with
Toxoplasma gondii
Resident Memory T-Cell Response to Herpes Simplex Virus Infection
Host Immune Cell Response to a Tissue Graft
Dendritic Cell Contribution to
Listeria
Infection
T-Cell Response to Tumors
Regulatory T Cells Inhibit the Immune Response in Multiple Ways
Conclusion
References
Study Questions
Chapter 15: Allergy, Hypersensitivities, and Chronic Inflammation
Allergies: Type I Hypersensitivity
IgE Antibodies Are Responsible for Type I Hypersensitivity
Many Allergens Can Elicit a Type I Response
IgE Antibodies Act by Binding Antigen, Resulting in the Cross-Linking of Fcε Receptors
IgE Receptor Signaling Is Tightly Regulated
Granulocytes Produce Molecules Responsible for Type I Hypersensitivity Symptoms
Type I Hypersensitivities Are Characterized by Both Early and Late Responses
There Are Several Categories of Type I Hypersensitivity Reactions
Susceptibility to Type I Hypersensitivity Reactions Is Influenced by Both Environmental Factors and Genetics
Diagnostic Tests and Treatments Are Available for Allergic Reactions
Why Did Allergic Responses Evolve?
Antibody-Mediated (Type II) Hypersensitivity
Transfusion Reactions Are an Example of Type II Hypersensitivity
Hemolytic Disease of the Newborn Is Caused by Type II Reactions
Hemolytic Anemia Can Be Drug Induced
Immune Complex–Mediated (Type III) Hypersensitivity
Immune Complexes Can Damage Various Tissues
Immune Complex–Mediated Hypersensitivity Can Resolve Spontaneously
Auto-Antigens Can Be Involved in Immune Complex–Mediated Reactions
Arthus Reactions Are Localized Type III Hypersensitivity Reactions
Delayed-Type (Type IV) Hypersensitivity
The Initiation of a Type IV DTH Response Involves Sensitization by Antigen
The Effector Phase of a Classical DTH Response Is Induced by Second Exposure to a Sensitizing Antigen
The DTH Reaction Can Be Detected by a Skin Test
Contact Dermatitis Is a Type IV Hypersensitivity Response
Chronic Inflammation
Infections Can Cause Chronic Inflammation
There Are Noninfectious Causes of Chronic Inflammation
Obesity Is Associated with Chronic Inflammation
Chronic Inflammation Can Cause Systemic Disease
Conclusion
References
Study Questions
Chapter 16: Tolerance, Autoimmunity, and Transplantation
Establishment and Maintenance of Tolerance
Antigen Sequestration, or Evasion, Is One Means to Protect Self Antigens from Attack
Central Tolerance Processes Occur in Primary Lymphoid Organs
Cells That Mediate Peripheral Tolerance Are Generated Outside Primary Lymphoid Organs
Multiple Immune Cell Types Work in the Periphery to Inhibit Anti-Self Responses
Autoimmunity
Some Autoimmune Diseases Target Specific Organs
Some Autoimmune Diseases Are Systemic
Both Intrinsic and Extrinsic Factors Can Favor Susceptibility to Autoimmune Disease
What
Causes
Autoimmunity?
Treatments for Autoimmune Disease Range from General Immune Suppression to Targeted Immunotherapy
Transplantation Immunology
Demand for Transplants Is High, but Organ Supplies Remain Low
Antigenic Similarity between Donor and Recipient Improves Transplant Success
Some Organs Are More Amenable to Transplantation Than Others
Matching Donor and Recipient Involves Prior Assessment of Histocompatibility
Allograft Rejection Follows the Rules of Immune Specificity and Memory
Graft Rejection Takes a Predictable Clinical Course
Immunosuppressive Therapy Can Be Either General or Target-Specific
Immune Tolerance to Allografts Is Favored in Certain Instances
Conclusion
References
Study Questions
Chapter 17: Infectious Diseases and Vaccines
The Importance of Barriers and Vectors in Infectious Disease
The Link between Location and Immune Effector Mechanism
Mucosal or Barrier Infections Are Typically Controlled by T
H
2-Type Responses
Extracellular Pathogens Must Be Recognized and Attacked Using Extracellular Tools
Mechanisms That Recognize Infected Host Cells Are Required to Combat Intracellular Infections
Viral Infections
The Antiviral Innate Response Provides Key Instructions for the Later Adaptive Response
Many Viruses Are Neutralized by Antibodies
Cell-Mediated Immunity is Important for Viral Control and Clearance
Viruses Employ Several Strategies to Evade Host Defense Mechanisms
The Imprinting of a Memory Response Can Influence Susceptibility to Future Viral Infection
Bacterial Infections
Immune Responses to Extracellular and Intracellular Bacteria Differ
Bacteria Can Evade Host Defense Mechanisms at Several Different Stages
Parasitic Infections
Protozoan Parasites Are a Diverse Set of Unicellular Eukaryotes
Parasitic Worms (Helminths) Typically Generate Weak Immune Responses
Fungal Infections
Innate Immunity Controls Most Fungal Infections
Immunity against Fungal Pathogens Can Be Acquired
Emerging and Re-emerging Infectious Diseases
Some Noteworthy New Infectious Diseases Have Appeared Recently
Diseases May Re-emerge for Various Reasons
Vaccines
Basic Research and Rational Design Advance Vaccine Development
Protective Immunity Can Be Achieved by Active or Passive Immunization
There Are Several Vaccine Strategies, Each with Unique Advantages and Challenges
Adding a Conjugate or Multivalent Component Can Improve Vaccine Immunogenicity
Adjuvants Are Included to Enhance the Immune Response to a Vaccine
Conclusion
References
Study Questions
Chapter 18: Immunodeficiency Diseases
Primary Immunodeficiencies
Primary Immunodeficiency Diseases Are Often Detected Early in Life
Combined Immunodeficiencies Disrupt Adaptive Immunity
B-Cell Immunodeficiencies Exhibit Depressed Production of One or More Antibody Isotypes
Disruptions to Innate Immune Components May Also Impact Adaptive Responses
Complement Deficiencies Are Relatively Common
NK-Cell Deficiencies Increase Susceptibility to Viral Infections and Cancer
Immunodeficiency Disorders That Disrupt Immune Regulation Can Manifest as Autoimmunity
Immunodeficiency Disorders Are Treated by Replacement Therapy
Animal Models of Immunodeficiency Have Been Used to Study Basic Immune Function
Secondary Immunodeficiencies
Secondary Immunodeficiencies May Be Caused by a Variety of Factors
HIV/AIDS Has Claimed Millions of Lives Worldwide
The Retrovirus HIV-1 Is the Causative Agent of AIDS
HIV-1 is Spread by Intimate Contact with Infected Body Fluids
In Vitro Studies Have Revealed the Structure and Life Cycle of HIV
HIV Variants with Preference for CCR5 or CXCR4 Coreceptors Play Different Roles in Infection
Infection with HIV Leads to Gradual Impairment of Immune Function
Changes over Time Lead to Progression to AIDS
Antiretroviral Therapy Inhibits HIV Replication, Disease Progression, and Infection of Others
A Vaccine May Be the Only Way to Stop the HIV/AIDS Pandemic
Conclusion
References
Study Questions
Chapter 19: Cancer and the Immune System
Terminology and the Formation of Cancer
Accumulated DNA Alterations or Translocation Can Induce Cancer
Genes Associated with Cancer Control Cell Proliferation and Survival
Malignant Transformation Involves Multiple Steps
Tumor Antigens
Tumor-Specific Antigens Contain Unique Sequences
Tumor-Associated Antigens Are Normal Cellular Proteins with Unique Expression Patterns
The Immune Response to Cancer
Immunoediting Can Both Protect Against and Promote Tumor Growth
Innate and Adaptive Pathways Participate in Cancer Detection and Eradication
Some Immune Response Elements Can Promote Cancer Survival
Tumor Cells Evolve to Evade Immune Recognition and Apoptosis
Anticancer Immunotherapies
Monoclonal Antibodies Can Be Used to Direct the Immune Response to Tumor Cells
Tumor-Specific T Cells Can Be Expanded, or Even Created
Therapeutic Vaccines May Enhance the Antitumor Immune Response
Manipulation of Comodulatory Signals, Using Checkpoint Blockade
Conclusion
References
Study Questions
Chapter 20: Experimental Systems and Methods
Antibody Generation
Polyclonal Antibodies Are Secreted by Multiple Clones of Antigen-Specific B Cells
A Monoclonal Antibody Is the Product of a Single Stimulated B Cell
Monoclonal Antibodies Can Be Modified for Use in the Laboratory or the Clinic
Immunoprecipitation- and Agglutination-Based Techniques
Immunoprecipitation Can Be Performed in Solution
Immunoprecipitation of Soluble Antigens Can Be Performed in Gel Matrices
Immunoprecipitation Enables Isolation of Specific Molecules from Cell and Tissue Extracts
Hemagglutination Reactions Can Be Used to Detect Any Antigen Conjugated to the Surface of Red Blood Cells
Hemagglutination Inhibition Reactions Are Used to Detect the Presence of Viruses and of Antiviral Antibodies
Bacterial Agglutination Can Be Used to Detect Antibodies to Bacteria
Antibody Assays Based on Molecules Bound to Solid-Phase Supports
Radioimmunoassays Are Used to Measure the Concentrations of Biologically Relevant Proteins and Hormones in Body Fluids
ELISAs Use Antibodies or Antigens Covalently Bound to Enzymes
ELISPOT Assays Measure Molecules Secreted by Individual Cells
Western Blotting Is an Assay That Can Identify a Specific Protein in a Complex Protein Mixture
Methods to Determine the Affinity of Antigen-Antibody Interactions
Equilibrium Dialysis Can Be Used to Measure Antibody Affinity for Antigen
Surface Plasmon Resonance Is Now Commonly Used for Measurements of Antibody Affinity
Antibody-Mediated Microscopic Visualization of Cells and Subcellular Structures
Immunocytochemistry and Immunohistochemistry Use Enzyme-Conjugated Antibodies to Create Images of Fixed Tissues
Immunoelectron Microscopy Uses Gold Beads to Visualize Antibody-Bound Antigens
Immunofluorescence-Based Imaging Techniques
Fluorescence Can Be Used to Visualize Cells and Molecules
Confocal Fluorescence Microscopy Provides Three-Dimensional Images of Extraordinary Clarity
Multiphoton Fluorescence Microscopy Is a Variation of Confocal Microscopy
Intravital Imaging Allows Observation of Immune Responses in Vivo
Visualization and Analysis of DNA Sequences in Intact Chromatin
Flow Cytometry and Cell Sorting
The Flow Cytometer Measures Scattered and Fluorescent Light from Cells Flowing Past a Laser Beam
Sophisticated Software Allows the Investigator to Identify Individual Cell Populations within a Sample
Flow Cytometers and Fluorescence-Activated Cell Sorters Have Important Clinical Applications
The Analysis of Multicolor Fluorescence Data Has Required the Development of Increasingly Sophisticated Software
CyTOF Uses Antibodies to Harness the Power of Mass Spectrometry
Magnets Can Be Used in a Gentle, Sterile Method for Sorting Cells
Cell Cycle Analysis
Tritiated Thymidine Uptake Was One of the First Methods Used to Assess Cell Division
Colorimetric Assays for Cell Division Are Rapid and Eliminate the Use of Radioactive Isotopes
Bromodeoxyuridine-Based Assays for Cell Division Use Antibodies to Detect Newly Synthesized DNA
Propidium Iodide Enables Analysis of the Cell Cycle Status of Cell Populations
Carboxyfluorescein Succinimidyl Ester Can Be Used to Follow Cell Division
Assays of Cell Death
The
51
Cr Release Assay Was the First Assay Used to Measure Cell Death
Fluorescently Labeled Annexin A5 Measures Phosphatidylserine in the Outer Lipid Envelope of Apoptotic Cells
The TUNEL Assay Measures Apoptotically Generated DNA Fragmentation
Caspase Assays Measure the Activity of Enzymes Involved in Apoptosis
Analysis of Chromatin Structure
Chromatin Immunoprecipitation Experiments Characterize Protein-DNA Interactions
Chromosome Conformation Capture Technologies Analyze Long-Range Chromosomal DNA Interactions
CRISPR-Cas9
Whole-Animal Experimental Systems
Animal Research Is Subject to Federal Guidelines That Protect Nonhuman Research Species
Inbred Strains Reduce Experimental Variation
Congenic Strains Are Used to Study the Effects of Particular Gene Loci on Immune Responses
Adoptive Transfer Experiments Allow in Vivo Examination of Isolated Cell Populations
Transgenic Animals Carry Genes That Have Been Artificially Introduced
Knock-in and Knockout Technologies Replace an Endogenous with a Nonfunctional or Engineered Gene Copy
The Cre/
lox
System Enables Inducible Gene Deletion in Selected Tissues
References
Study Questions
Appendix I: CD Antigens
Appendix II: Cytokines and Associated JAK-STAT Signaling Molecules
Appendix III: Chemokines and Chemokine Receptors
Glossary
Answers to Study Questions
Index